HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Davide Fattore Selected Research

Therapeutics

3/2024Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study.
7/2023Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force "Dermatology for Cancer Patients" International Study.
1/2023Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience.
1/2023Comment on "Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes".
12/2022Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients.
5/2022Scleroderma-like Syndrome in the Setting of Pembrolizumab Therapy for Non-Small Cell Lung Cancer: Diagnosis and Dermatologic Management.
1/2021Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors.
5/2020The pharmacology of antibiotic therapy in hidradenitis suppurativa.
11/2018Bullous pemphigoid and nivolumab: Dermatologic management to support and continue oncologic therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Davide Fattore Research Topics

Disease

9Neoplasms (Cancer)
03/2024 - 01/2022
4Psoriasis (Pustulosis Palmaris et Plantaris)
03/2024 - 03/2019
3Alopecia (Baldness)
10/2023 - 11/2022
3Hidradenitis Suppurativa
01/2023 - 04/2019
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 05/2022
2Breast Neoplasms (Breast Cancer)
07/2023 - 01/2021
2Pyogenic Granuloma
12/2021 - 01/2021
2Acne Vulgaris
04/2019 - 01/2019
1Acrodermatitis (Gianotti Crosti Syndrome)
01/2024
1Monilethrix
10/2023
1Brain Neoplasms (Brain Tumor)
08/2023
1Meningioma (Meningiomas)
08/2023
1Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis)
01/2023
1Pruritus (Itching)
12/2022
1Exanthema (Rash)
12/2022
1Asthma (Bronchial Asthma)
01/2022
1Skin Diseases (Skin Disease)
01/2022
1Atopic Dermatitis (Atopic Eczema)
10/2021
1Vitiligo
01/2021
1Scabies (Sarcoptic Mange)
10/2019
1Allergic Contact Dermatitis
05/2019
1Pyoderma Gangrenosum
04/2019
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2019
1Prurigo
01/2019
1Bullous Pemphigoid (Pemphigoid)
11/2018

Drug/Important Bio-Agent (IBA)

6Immune Checkpoint InhibitorsIBA
01/2024 - 03/2019
2Cyclin-Dependent Kinases (cdk Proteins)IBA
07/2023 - 01/2021
2Estrogen ReceptorsIBA
07/2023 - 01/2021
2pembrolizumabIBA
05/2022 - 01/2019
2apremilastIBA
05/2021 - 03/2019
1atezolizumabIBA
01/2024
1Protons (Proton)IBA
08/2023
1Cyclin-Dependent Kinase 4IBA
07/2023
1ErbB Receptors (EGF Receptor)IBA
07/2023
1Clindamycin (Cleocin)FDA LinkGeneric
01/2023
1Rifampin (Rifampicin)FDA LinkGeneric
01/2023
1Minoxidil (Rogaine)FDA LinkGeneric
11/2022
1dupilumabIBA
01/2022
1Capecitabine (Xeloda)FDA Link
12/2021
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
10/2021
1AcitretinFDA Link
05/2021
1Methotrexate (Mexate)FDA LinkGeneric
05/2021
1Propranolol (Inderal)FDA LinkGeneric
01/2021
1CyclinsIBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
05/2020
1Permethrin (Ambush)FDA LinkGeneric
10/2019
1MentholFDA Link
10/2019
1ChlorhexidineIBA
10/2019
1CamphorIBA
10/2019
1naftifine (naftifine hydrochloride)FDA Link
05/2019
1Adalimumab (Humira)FDA Link
04/2019
1Immunoglobulin A (IgA)IBA
01/2019
1NivolumabIBA
11/2018

Therapy/Procedure

9Therapeutics
03/2024 - 11/2018
4Drug Therapy (Chemotherapy)
10/2023 - 11/2022
2Immunotherapy
01/2024 - 01/2023
1Biological Therapy
03/2024
1Adjuvant Radiotherapy
08/2023
1Radiotherapy
08/2023
1Proton Therapy
08/2023
1Skin Care
10/2021